Bull
$4.30
Szenariopreis
$1.200
+0.063 (+5.26%)Zum Schluss
eHealth, Inc. is an independent licensed insurance agency and advisor. It is a private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Its segments include Medicare and Employer and Individual (E&I). The Medicare segment markets Medicare-related health insurance plans and, to a lesser extent, ancillary products such as dental and vision insurance and hospital indemnity plans, to its Medicare-eligible consumers. Its Medicare ecommerce platform can be accessed through its Websites www.eHealthMedicare.com and www.GoMedigap.com, along with its telephonic enrollment capabilities. The E&I segment markets individual and family health insurance plans, along with employer plans, which include small business health insurance plans and individual coverage health reimbursement arrangements. It also markets a variety of ancillary products, including short-term, dental and vision plans.
eHealth Inc is currently trading at $1.20, which is significantly below analyst price targets of $2 and $3, suggesting potential upside. However, the company's recent performance shows a concerning 71.83% year-to-date decline and a 45% year-over-year revenue drop in Q2, indicating significant challenges. The RSI at 46.074 suggests the stock is near neutral territory, and while the lifetime advisory model shows promise, the overall market sentiment remains cautious due to declining earnings estimates in the insurance brokerage sector. Given these factors, it may be prudent to hold rather than buy at this time, as risks outweigh potential rewards.
RBC Capital
$2
2026-08-25
RBC Capital
2026-08-25
Kursziel
$2
Deutsche Bank
$3
2026-05-08
Deutsche Bank
2026-05-08
Kursziel
$3
RBC Capital
$3
2026-03-11
RBC Capital
2026-03-11
Kursziel
$3
Deutsche Bank
$2
2026-02-27
Deutsche Bank
2026-02-27
Kursziel
$2
Craig-Hallum
$2
2026-02-26
Craig-Hallum
2026-02-26
Kursziel
$2
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Many Americans Underestimate Financial Risks of Medicare

eHealth, Inc. Q2 2026 Earnings Call Insights

eHealth, Inc. Reports Q2 2026 Financial Results

eHealth to Release Q2 2026 Financial Results on August 4

eHealth to Release Q2 2026 Financial Results on August 4
eHealth, Inc. is an independent licensed insurance agency and advisor. It is a private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Its segments include Medicare and Employer and Individual (E&I). The Medicare segment markets Medicare-related health insurance plans and, to a lesser extent, ancillary products such as dental and vision insurance and hospital indemnity plans, to its Medicare-eligible consumers. Its Medicare ecommerce platform can be accessed through its Websites www.eHealthMedicare.com and www.GoMedigap.com, along with its telephonic enrollment capabilities. The E&I segment markets individual and family health insurance plans, along with employer plans, which include small business health insurance plans and individual coverage health reimbursement arrangements. It also markets a variety of ancillary products, including short-term, dental and vision plans. It operates in the Financials sector (INSURANCE AGENTS, BROKERS & SERVICE industry).
eHealth Inc is currently trading at $1.20, which is significantly below analyst price targets of $2 and $3, suggesting potential upside. However, the company's recent performance shows a concerning 71.83% year-to-date decline and a 45% year-over-year revenue drop in Q2, indicating significant challenges. The RSI at 46.074 suggests the stock is near neutral territory, and while the lifetime advisory model shows promise, the overall market sentiment remains cautious due to declining earnings estimates in the insurance brokerage sector. Given these factors, it may be prudent to hold rather than buy at this time, as risks outweigh potential rewards.
5 analysts cover EHTH: 3 rate it Buy, 2 Hold and 0 Sell. The average price target is 9.67.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.